---
image: "../images/hero_01.jpg"
mobile_image: "../images/mobile_hero_01.jpg"
buttons:
- template: hero-button
  variant: outlined
  color: primary
  buttonText: 了解更多
  link: products-and-services/take2-prophecy
  internal: true
  button_text: 了解更多
  name: common.learn_more
- template: hero-button
  variant: contained
  color: secondary
  internal: false
  button_text: 立即預約
  link: https://take2health.net/health-platform/
  name: common.book_now
reference: "¹Chan, K. C. Allen, et al. “Analysis of Plasma Epstein–Barr Virus DNA
  to Screen for Nasopharyngeal Cancer.”<i>New England Journal of Medicine</i>, vol.
  377, no. 6, 2017, pp. 513–22."
mobileImage: "../images/top-banner-girl.jpg"
theme: light
sort: 2
titleCn: Take2 Prophecy™<br />早期鼻咽癌筛查
titleEn: The Take2 Prophecy™<br />Test for Nasopharyngeal Cancer
detailCn: 超越既有，引领医学，Take2 Prophecy™ 早期鼻咽癌筛查结合PCR及高通量測序技術 ，能有效检测到早期鼻咽癌。数据显示，越早发现癌症，治疗的效果就会越好，而存活率也能大幅提升¹。早期鼻咽癌没有明显病征，许多患者未有及时检测，因而未能了解身体状况，错失治疗的黄金期。懂得准备，便没有跨不过的难关。
detailEn: |-
  Early diagnosis of NPC is difficult as the symptoms of NPC are subtle and non-specific. This often leads to delay in diagnosis and missing the golden opportunity of treatment. However, with the availability of the Take2 Prophecy™ Test for Nasopharyngeal Cancer (NPC), patients can now be more prepared and confident to overcome the uphill battle.
  The Take2 Prophecy™ Test for NPC is a pioneering test combining Polymerase Chain Reaction (PCR) and Next-generation Sequencing (NGS) technologies. It is clinically proven to deliver remarkably accurate and reliable results for early NPC detection. Extensive research indicates that early diagnosis could enable more effective treatments, hence the survival rate is increased¹. Let’s get tested and start taking control of your health!
titleHk: Take2 Prophecy™<br />早期鼻咽癌篩查
detailHk: 超越既有，引領醫學，Take2 Prophecy™ 早期鼻咽癌篩查結合PCR及次世代DNA測序技術，能有效檢測到早期鼻咽癌。數據顯示，越早發現癌症，治療的效果就會越好，而存活率也能大幅提升¹。早期鼻咽癌沒有明顯病徵，許多患者未有及時檢測，因而未能了解身體狀況，錯失治療的黃金期。懂得準備，便沒有跨不過的難關。

---
